We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MF:EURONEXT PARISWendel SE Analysis

Data as of 2026-06-28 - not real-time

$40.29

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Manulife Financial Corp (MF) is trading at $40.29, comfortably above its 20‑day (≈39.52) and 50‑day (≈39.09) simple moving averages while still below the 200‑day SMA (≈35.78), indicating a short‑term bullish bias within a longer‑term uptrend. The MACD line (≈0.48) sits just above its signal (≈0.48) and the histogram is positive, reinforcing the bullish momentum, while the RSI of 58 suggests the stock is not yet overbought. Fundamentally, the company trades at a forward PE of 11.6 versus an industry average of 16.9, and its DCF‑derived fair value of $76.6 implies substantial upside potential. Revenue growth of 12.1% and a solid operating margin of 19% highlight strong top‑line momentum, and the balance sheet is robust with cash exceeding debt (≈$30.3B cash vs $23.5B debt). Dividend yield stands at 3.31% with a payout ratio of 52%, supporting a sustainable income stream. Recent news of preferred‑share conversions is a neutral capital‑structure event that should not materially affect valuation.
Overall, the stock exhibits moderate volatility (≈24.7% 30‑day) but a low beta (≈0.85), suggesting resilience against market swings. The combination of undervaluation signals, attractive dividend, and solid cash generation makes MF a compelling candidate for investors seeking a blend of growth and income, provided they are comfortable with the modest liquidity decline and sector‑specific regulatory considerations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical setup (price above SMA20/50, bullish MACD)
  • Strong dividend yield and sustainable payout
  • Decreasing volume indicating potential short‑term consolidation

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value far above current price suggesting upside
  • Robust cash generation and low leverage
  • Revenue growth above 10% with solid margins

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend and attractive yield
  • Stable balance sheet with cash exceeding debt
  • Diversified geographic exposure reducing concentration risk

Key Metrics & Analysis

Financial Health

Revenue Growth12.10%
Profit Margin20.04%
P/E Ratio16.5
ROE12.56%
ROA0.59%
Debt/Equity44.28
P/B Ratio2.0
Op. Cash Flow$28.8B
Free Cash Flow$5.5B
Industry P/E16.9

Technical Analysis

TrendBullish
RSI58.1
Support$36.84
Resistance$41.43
MA 20$39.52
MA 50$39.09
MA 200$35.78
MACDBullish
VolumeDecreasing
Fear & Greed Index88.55

Valuation

Fair Value$76.61
Target Price$33.50
Upside/Downside-16.86%
GradeUndervalued
TypeBlend
Dividend Yield3.31%

Risk Assessment

Beta0.85
Volatility24.70%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.